GEMCITABINE AND S-1 COMBINATION THERAPY IN PATIENTS WITH ADVANCED STAGE OF PANCREATIC CANCER

被引：0

作者：

Ouchi, J. ^{[1
]}

Hijioka, M. ^{[1
]}

Harada, S. ^{[1
]}

Maruyama, Y. ^{[1
]}

Funakoshi, A. ^{[1
]}

机构：

[1] Kyushu Natl Canc Ctr, Dept Gastroenterol, Fukuoka, Japan

来源：

PANCREAS | 2008年 / 37卷 / 04期

关键词：

D O I：

10.1097/01.MPA.0000335356.63524.1b

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：488 / 488

页数：1

共 50 条

[1] S-1 IN COMBINATION WITH GEMCITABINE FOR ADVANCED PANCREATIC CANCER
Sudo, K.
Yamaguchi, T.
Nakamura, K.
Hara, T.
Ishihara, T.
Denda, T.
ANNALS OF ONCOLOGY, 2008, 19 : 185 - 185
[2] Clinical outcome of gemcitabine/S-1 combination therapy for advanced pancreatic cancer
Yamauchi, Junichi
Kanai, Masashi
Matsumoto, Shigemi
Nishimura, Takafumi
Yazumi, Shujiro
Kami, Kazuhiro
Kawaguchi, Yoshiya
Yasuda, Hiroyasu
Kitano, Toshiyuki
Misawa, Akiko
Ishiguro, Hiroshi
Yoshikawa, Kiyotsugu
Yanagihara, Kazuhiro
Fukushima, Masanori
Doi, Ryuichiro
Chiba, Tsutomu
PANCREAS, 2008, 36 (03) : 327 - 328
[3] Combination therapy of gemcitabine and S-1 in patients with metastatic pancreatic cancer
Yamaguchi, Taketo
Nakamura, Kazuyoshi
Sudou, Kentarou
Hara, Tarou
Denda, Tadamichi
Ishihara, Takeshi
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A89 - A89
[4] Phase I study of gemcitabine and S-1 combination therapy in patients with advanced pancreatic cancer
Ueno, H
Okusaka, T
Ikeda, M
Takezako, Y
Morizane, C
Furuse, J
Ishii, H
Nagase, M
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 353S - 353S
[5] A phase II trial of gemcitabine, S-1 and LV combination therapy in patients with advanced pancreatic cancer
Saito, K. O.
Nakai, Y.
Isayama, H.
Ishigaki, K.
Saito, T.
Takahara, N.
Mizuno, S.
Kogure, H.
Koike, K.
ANNALS OF ONCOLOGY, 2018, 29
[6] A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer
Saito, Kei
Isayama, Hiroyuki
Nakai, Yousuke
Takahara, Naminatsu
Ishigaki, Kazunaga
Takeda, Tsuyoshi
Hakuta, Ryunosuke
Saito, Tomotaka
Uchino, Rie
Kishikawa, Takahiro
Hamada, Tsuyoshi
Mizuno, Suguru
Sasaki, Takashi
Kogure, Hirofumi
Matsubara, Saburo
Yamamoto, Natsuyo
Ijichi, Hideaki
Tateishi, Keisuke
Tada, Minoru
Koike, Kazuhiko
INVESTIGATIONAL NEW DRUGS, 2019, 37 (02) : 338 - 344
[7] A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer
Kei Saito
Hiroyuki Isayama
Yousuke Nakai
Naminatsu Takahara
Kazunaga Ishigaki
Tsuyoshi Takeda
Ryunosuke Hakuta
Tomotaka Saito
Rie Uchino
Takahiro Kishikawa
Tsuyoshi Hamada
Suguru Mizuno
Takashi Sasaki
Hirofumi Kogure
Saburo Matsubara
Natsuyo Yamamoto
Hideaki Ijichi
Keisuke Tateishi
Minoru Tada
Kazuhiko Koike
Investigational New Drugs, 2019, 37 : 338 - 344
[8] A phase 1 trial of GSL (gemcitabine, S-1, LV) combination therapy in advanced pancreatic cancer
Nakai, Yousuke
Isayama, Hiroyuki
Sasaki, Takashi
Saito, Kei
Takahara, Naminatsu
Mizuno, Suguru
Hamada, Tsuyoshi
Miyabayashi, Koji
Yamamoto, Keisuke
Kogure, Hirofumi
Yamamoto, Natsuyo
Hirano, Kenji
Ijichi, Hideaki
Tateishi, Keisuke
Tada, Minoru
Koike, Kazuhiko
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
[9] Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer A Systematic Review and Meta-Analysis
Li, Doudou
Chen, Changhao
Zhou, Yu
Chen, Rufu
Fan, Xinxiang
Bi, Zhuofei
Li, Zhihua
Liu, Yimin
MEDICINE, 2015, 94 (35) : e1345
[10] A phase I trial of gemcitabine, S-1 and LV combination (GSL) therapy in advanced pancreatic cancer
Nakai, Yousuke
Isayama, Hiroyuki
Saito, Kei
Sasaki, Takashi
Takahara, Naminatsu
Hamada, Tsuyoshi
Mizuno, Suguru
Miyabayashi, Koji
Yamamoto, Keisuke
Mohri, Dai
Kogure, Hirofumi
Yamamoto, Natsuyo
Hirano, Kenji
Ijichi, Hideaki
Tateishi, Keisuke
Tada, Minoru
Koike, Kazuhiko
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (05) : 911 - 915

← 1 2 3 4 5 →